Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996

Psychiatric Services

Volumn 53, Issue 3, 2002, Pages 337-339

  Mojtabai, Ramin ^a   Lavelle, Janet ^a   Gibson, P Joseph ^a   Sohler, Nancy L ^a   Craig, Thomas J ^a   Carlson, Gabrielle A ^a   Bromet, Evelyn J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; DRUG EFFICACY; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANTIPSYCHOTIC AGENTS; BENCHMARKING; CONTINUITY OF PATIENT CARE; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; PATIENT ADMISSION; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 0036187764     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.53.3.337     Document Type: Article

References (10)

1. Neuroleptic withdrawal in schizophrenic patients: A review of the literature
2. Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations
3. The content and context of adherence
4. In conclusion: Does antipsychotic treatment modify the long-term course of schizophrenia illness?
5. Medication adherence in psychosis: Predictors and impact on outcome: A 2-year follow-up of first-admitted subjects
6. Treatment adherence in first-episode schizophrenia
7. The epidemiology of psychosis: The Suffolk County Mental Health Project
8. Building a useful pharmacotherapy data set from multiple sources
9. Identifying risk factors and key strategies in linkage to outpatient psychiatric care
10. Medication continuation and compliance: A comparison of patients treated with clozapine and haloperidol